Objectives

1. Describe relationships between markers of CKD severity and outcomes.

2. Weigh accumulating evidence for novel biomarkers for CKD and CVD in patients with CKD and kidney transplant recipients.

Session date: 
Thursday, September 27, 2018 - 1:00pm to 2:00pm
Speaker Name: 
Brad Astor, PhD, MPH
Location: 
UCMC AMB S-534
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.